Document Detail


Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
MedLine Citation:
PMID:  21953299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: OPN was more sensitive than AFP for the diagnosis of HCC in all studied HCC groups. In addition, OPN performance remained intact in samples collected 1 year before diagnosis.
Authors:
Sufen Shang; Amelie Plymoth; Shaokui Ge; Ziding Feng; Hugo R Rosen; Suleeporn Sangrajrang; Pierre Hainaut; Jorge A Marrero; Laura Beretta
Related Documents :
22865299 - Shorter peripheral blood telomeres are a potential biomarker for patients with advanced...
21909639 - Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.
22249289 - Patterns of white matter diffusivity abnormalities in leber's hereditary optic neuropat...
22491589 - Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancer...
20484899 - Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells...
17485889 - Increased remnant lipoprotein in patients with coronary artery disease--evaluation util...
1121649 - Folic acid deficiency in sickle cell anaemia.
14706219 - Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations.
453299 - Vasoactive intestinal polypeptide in tissues of the human female reproductive tract.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-12-19
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  55     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-30     Completed Date:  2012-03-25     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  483-90     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 American Association for the Study of Liver Diseases.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Hepatocellular / blood*,  diagnosis
Humans
Liver Neoplasms / blood*,  diagnosis
Male
Mass Spectrometry
Osteopontin / blood*
Proteomics
Tumor Markers, Biological / blood*
Grant Support
ID/Acronym/Agency:
R01 CA120719/CA/NCI NIH HHS; R01 DK066840/DK/NIDDK NIH HHS; R01CA120719/CA/NCI NIH HHS; R01DK066840/DK/NIDDK NIH HHS; T32 CA009168/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological; 106441-73-0/Osteopontin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Asymmetric properties of long-term and total heart rate variability.
Next Document:  Intravitreal bevacizumab for severe vaso-occlusive retinopathy in systemic lupus erythematosus.